Defining a pharmacological inhibitor fingerprint for oxytosis/ferroptosis

Ferroptosis was first described in 2012 as an iron- and lipid peroxidation-dependent form of regulated cell death. Since its initial description, these two characteristics have informed numerous Cell Culture studies where inhibitors of lipid peroxidation and/or iron chelators have been shown to prevent cell death induced by a wide range of insults. However, it is not clear whether these two characteristics are sufficient to distinguish Ferroptosis from other forms of regulated cell death. Thus, the primary goal of this study was to determine whether a unique combination of features could be identified that would provide an approach to more clearly separate Ferroptosis from other forms of regulated cell death. To this end, multiple pharmacological inhibitors based on a variety of studies were tested. Many of these inhibitors were previously shown to protect cells from oxytosis, a regulated cell death pathway that mechanistically overlaps with Ferroptosis and is induced by some of the same chemicals as Ferroptosis. These inhibitors were not only tested against both known Ferroptosis and oxytosis inducers but also a number of other insults that have been suggested to induce Ferroptosis. The results show that a pharmacological fingerprint for Ferroptosis can be established and used to categorize toxic insults into those that overlap with oxytosis/Ferroptosis and those that do not.